Also trades as: 4582.T (JPX) · $vol 0M

$0.56

+0.00 (+0.00%)

OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Strong Sell · Power 39 · $26.4M mcap · 50M float · 0.0005% daily turnover · Short 89% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

Income Trends

Revenue

$1.4B -44.1% ▼

5Y CAGR: -14.4%

Gross Profit

$993M -47.0% ▼

5Y CAGR: +2.8%

Operating Income

-$4.7B -20.1% ▼

Net Income

-$5.0B -30.6% ▼

EPS (Diluted)

$-99.73 -18.6% ▼

EBITDA

-$4.8B -27.6% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$8.3B	$10.0B	$5.6B	$2.5B	$1.4B
YoY Growth	+176.3%	+21.3%	-44.1%	-56.1%	-44.1%
Cost of Revenue	$2.5B	$2.4B	$1.2B	$580M	$378M
Gross Profit	$5.8B	$7.6B	$4.4B	$1.9B	$993M
Gross Margin	70.3%	75.9%	78.9%	76.4%	72.4%
R&D Expenses	$1.7B	$2.6B	$2.6B	$0	$3.5B
SG&A Expenses	$3.0B	$3.1B	$2.6B	$2.4B	$2.2B
Operating Expenses	$4.8B	$5.6B	$5.2B	$5.8B	$5.6B
Operating Income	$1.0B	$2.0B	-$812M	-$3.9B	-$4.7B
Operating Margin	12.3%	19.6%	-14.5%	-158.1%	-339.6%
Interest Expense	$2M	$0	$11M	$20M	$157M
Income Before Tax	$1.0B	$2.1B	-$1.2B	-$3.8B	-$5.0B
Tax Expense	-$1.0B	$927M	$767M	$27M	$29M
Net Income	$2.0B	$1.2B	-$2.0B	-$3.8B	-$5.0B
Net Margin	24.6%	11.8%	-35.1%	-156.3%	-365.3%
EPS (Diluted)	$52.32	$29.77	$-49.19	$-84.06	$-99.73
EBITDA	$1.1B	$2.1B	-$716M	-$3.8B	-$4.8B
Shares Outstanding	39M	40M	40M	46M	50M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$614M	$554M	$264M	$383M	$330M	$337M	$238M	$240M
Cost of Revenue	$166M	$125M	$62M	$91M	$124M	$86M	$62M	$72M
Gross Profit	$448M	$429M	$202M	$291M	$205M	$294M	$176M	$167M
Gross Margin	73.0%	77.4%	76.7%	76.1%	62.3%	87.4%	74.0%	69.9%
R&D Expenses	$961M	$886M	$819M	$819M	$884M	$862M	$2.0B	$1.0B
SG&A Expenses	$559M	$628M	$552M	$4M	$528M	$516M	$532M	$460M
Operating Expenses	$1.5B	$1.5B	$1.4B	$1.3B	$1.4B	$1.4B	$2.6B	$1.5B
Operating Income	-$1.1B	-$1.1B	-$1.2B	-$985M	-$1.2B	-$1.1B	-$2.4B	-$1.3B
Operating Margin	-174.5%	-196.0%	-442.8%	-257.4%	-365.7%	-326.9%	-1002.8%	-547.1%
Interest Expense	$0	$0	$6M	$357K	$11M	$12M	$17M	$18M
Income Before Tax	-$1.3B	-$982M	-$1.3B	-$1.0B	-$1.2B	-$1.2B	-$2.4B	-$1.2B
Tax Expense	$5M	$6M	$12M	$14K	-$4M	$19M	$14M	$4M
Net Income	-$1.3B	-$988M	-$1.3B	-$1.0B	-$1.2B	-$1.2B	-$2.4B	-$1.2B
Net Margin	-212.3%	-178.5%	-500.5%	-273.8%	-369.0%	-359.4%	-1028.6%	-515.2%
EPS (Diluted)	$-28.45	$-21.55	$-27.95	$-22.16	$-24.53	$-28.31	$-36.75	$-16.15
EBITDA	-$1.0B	-$1.1B	-$135M	-$7M	-$1.2B	-$1.2B	-$2.4B	-$1.3B
Shares Outstanding	46M	46M	47M	47M	50M	50M	67M	76M

SYMQY OTC

Income Trends

Profit Margins

Year-over-Year Growth

Sign in to InsiderStreet